Home
/ MSD
/ Competitors

MSD Competitors and Similar CompaniesClear all

MSD's competitors and similar companies include CSPC Pharmaceutical Group, Sandoz, Sanofi Pasteur and McKesson Europe.

	MSD MSD (Merck Sharp & Dohme) is a pharmaceutical company.	CSPC Pharmaceutical Group CSPC Pharmaceutical Group (石药集团有限公司) is a pharmaceutical company engaged in drug development and production.	Sandoz Sandoz is a company operating in generic and biosimilar medicines.	Sanofi Pasteur Sanofi Pasteur is a pharmaceutical company that develops, manufactures, and supplies vaccines.	McKesson Europe McKesson Europe is a trading company that provides logistics and services in the pharmaceutical and healthcare sector.
Founding Date	Founding Date 1891	Founding Date N/A	Founding Date 1886	Founding Date 1989	Founding Date 1835
Type	Type Subsidiary	Type Public	Type Private	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Wien, AT HQ Krems An Der Donau, AT Wien, AT Wien, AT	Locations Shijiazhuang, CN HQ Hong Kong, HK	Locations Holzkirchen, DE HQ Basel, CH Broomfield, US East Hanover, US Princeton, US	Locations Lyon, FR HQ	Locations Stuttgart, DE HQ
Employees	Employees 311	Employees 21,4005% increase	Employees 17,067	Employees 6,7454% increase	Employees 26,329
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥26b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €2.8b (FY, 2021)	Revenue (est.) €18b (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods ¥7.5b (FY, 2025)	Cost of goods N/A	Cost of goods €505m (FY, 2021)	Cost of goods €16.1b (FY, 2022)
Gross profit	Gross profit N/A	Gross profit ¥19b (FY, 2025)	Gross profit N/A	Gross profit €2.3b (FY, 2021)	Gross profit €1.9b (FY, 2022)
Net income	Net income N/A	Net income ¥3.9b (FY, 2025)	Net income N/A	Net income €605m (FY, 2021)	Net income (€867.4m) (FY, 2022)